STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
13 Novembre 2024 - 1:00PM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of the EVO family of Implantable
Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia,
invites investors and the general public to listen to a webcast
fireside chat with STAAR Management at the upcoming Stephens Annual
Investment Conference, which will be held in Nashville, TN.
Event: Stephens Annual Investment Conference (NASH2024)
Management Attendee: Patrick F. Williams, Chief Financial Officer
Date: Wednesday, November 20, 2024 Time: 11:00 a.m. ET / 8:00 a.m.
PT Location: Live Webcast
The live webcast link includes an option to pre-register. An
online replay of the webcast will also be available on STAAR’s
investor website at https://investors.staar.com/.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 40 years, designs, develops, manufactures and markets
implantable lenses for the eye. These lenses are intended to
provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are
foldable, which permits the surgeon to insert them through a small
incision. STAAR’s lens used in refractive surgery is called an
Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™
product line. More than 3,000,000 ICLs have been sold to date and
STAAR markets these lenses in over 75 countries. To learn more
about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241113681040/en/
Investors & Media Brian Moore Vice President,
Investor Relations and Corporate Development (626) 303-7902, Ext.
3023 bmoore@staar.com
Connie Johnson Director, Investor Relations and HPMS (626)
303-7902, Ext. 2207 cjohnson@staar.com
Grafico Azioni STAAR Surgical (NASDAQ:STAA)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni STAAR Surgical (NASDAQ:STAA)
Storico
Da Dic 2023 a Dic 2024
